Amedeo Smart

Free Medical Literature Service



Colorectal Neoplasms

  Free Subscription


1 Am J Surg
3 Ann Oncol
3 Ann Surg
4 Anticancer Res
1 BMC Gastroenterol
4 Br J Cancer
1 Cancer
1 Cancer Lett
1 Cancer Res
3 Clin Cancer Res
12 Dis Colon Rectum
2 Eur J Surg Oncol
3 Gastroenterology
1 Gastrointest Endosc
6 Int J Cancer
2 Int J Colorectal Dis
1 J Surg Oncol
2 Lancet Oncol
1 Oncogene
10 PLoS One
2 Semin Oncol
1 World J Surg

    Am J Surg

  1. ALTHANS AR, Brady JT, Keller DS, Stein SL, et al
    Are we catching women in the safety net? Colorectal cancer outcomes by gender at a safety net hospital.
    Am J Surg. 2017;214:715-720.
    >> Share

    Ann Oncol

  2. SOBRERO A, Damiani A
    Maintenance therapy in advanced colorectal cancer, yes or no? Ask the laboratory.
    Ann Oncol. 2017;28:2043-2044.
    >> Share

  3. WEI Q, Ye Z, Zhong X, Li L, et al
    Multiregion whole-exome sequencing of matched primary and metastatic tumors revealed genomic heterogeneity and suggested polyclonal seeding in colorectal cancer metastasis.
    Ann Oncol. 2017;28:2135-2141.
    >> Share

  4. GOEY KKH, Elias SG, van Tinteren H, Lacle MM, et al
    Maintenance treatment with capecitabine and bevacizumab versus observation in metastatic colorectal cancer: updated results and molecular subgroup analyses of the phase 3 CAIRO3 study.
    Ann Oncol. 2017;28:2128-2134.
    >> Share

    Ann Surg

  5. MARGONIS GA, Buettner S, Andreatos N, Sasaki K, et al
    Anatomical Resections Improve Disease-free Survival in Patients With KRAS-mutated Colorectal Liver Metastases.
    Ann Surg. 2017;266:641-649.
    >> Share

  6. SUJATHA-BHASKAR S, Jafari MD, Gahagan JV, Inaba CS, et al
    Defining the Role of Minimally Invasive Proctectomy for Locally Advanced Rectal Adenocarcinoma.
    Ann Surg. 2017;266:574-581.
    >> Share

  7. KELLEY KA, Ruhl RA, Rana SR, Dewey E, et al
    Understanding and Resetting Radiation Sensitivity in Rectal Cancer.
    Ann Surg. 2017;266:610-616.
    >> Share

    Anticancer Res

  8. KANEKO M, Nozawa H, Emoto S, Murono K, et al
    Neoadjuvant Imatinib Therapy Followed by Intersphincteric Resection for Low Rectal Gastrointestinal Stromal Tumors.
    Anticancer Res. 2017;37:5155-5160.
    >> Share

  9. ANNEDE P, Darreon J, Benkemouche A, Valdenaire S, et al
    Flattening Filter Free vs. Flattened Beams for Lung Stereotactic Body Radiation Therapy.
    Anticancer Res. 2017;37:5133-5139.
    >> Share

  10. NONAKA T, Fukuda A, Maekawa K, Nagayoshi S, et al
    Clinical and Oncological Outcomes of Laparoscopic Lateral Pelvic Lymph Node Dissection in Advanced Lower Rectal Cancer: Single-institution Experience.
    Anticancer Res. 2017;37:5095-5100.
    >> Share

  11. CARINI F, Mazzola M, Rappa F, Jurjus A, et al
    Colorectal Carcinogenesis: Role of Oxidative Stress and Antioxidants.
    Anticancer Res. 2017;37:4759-4766.
    >> Share

    BMC Gastroenterol

  12. BARONTINI J, Antinucci M, Tofanelli S, Cammalleri M, et al
    Association between polymorphisms of TAS2R16 and susceptibility to colorectal cancer.
    BMC Gastroenterol. 2017;17:104.
    >> Share

    Br J Cancer

  13. ALLARD MA, Adam R, Giuliante F, Lapointe R, et al
    Long-term outcomes of patients with 10 or more colorectal liver metastases.
    Br J Cancer. 2017;117:604-611.
    >> Share

  14. GIAMPIERI R, Puzzoni M, Daniele B, Ferrari D, et al
    First-line FOLFIRI and bevacizumab in patients with advanced colorectal cancer prospectively stratified according to serum LDH: final results of the GISCAD (Italian Group for the Study of Digestive Tract Cancers) CENTRAL (ColorEctalavastiNTRiAlLdh) tr
    Br J Cancer. 2017 Sep 19. doi: 10.1038/bjc.2017.
    >> Share

  15. BROWN JC, Zemel BS, Troxel AB, Rickels MR, et al
    Dose-response effects of aerobic exercise on body composition among colon cancer survivors: a randomised controlled trial.
    Br J Cancer. 2017 Sep 21. doi: 10.1038/bjc.2017.
    >> Share

  16. CALLAHAN CL, Schwartz K, Ruterbusch JJ, Shuch B, et al
    Leukocyte telomere length and renal cell carcinoma survival in two studies.
    Br J Cancer. 2017;117:752-755.
    >> Share


  17. MALAPELLE U, Mayo-de-Las-Casas C, Molina-Vila MA, Rosell R, et al
    Consistency and reproducibility of next-generation sequencing and other multigene mutational assays: A worldwide ring trial study on quantitative cytological molecular reference specimens.
    Cancer. 2017;125:615-626.
    >> Share

    Cancer Lett

  18. SUN LN, Zhi Z, Chen LY, Zhou Q, et al
    SIRT1 suppresses colorectal cancer metastasis by transcriptional repression of miR-15b-5p.
    Cancer Lett. 2017 Sep 15. pii: S0304-3835(17)30548.
    >> Share

    Cancer Res

  19. KATHER JN, Poleszczuk J, Suarez-Carmona M, Krisam J, et al
    In silico modeling of immunotherapy and stroma-targeting therapies in human colorectal cancer.
    Cancer Res. 2017 Sep 18. pii: canres.2006.2017.
    >> Share

    Clin Cancer Res

  20. JIAO HL, Ye YP, Yang RW, Sun HY, et al
    Down-regulation of SAFB sustains the NF-kappaB pathway by targeting TAK1 during the progression of colorectal cancer.
    Clin Cancer Res. 2017 Sep 14. pii: clincanres.0747.2017.
    >> Share

  21. BARTOLOME RA, Aizpurua C, Jaen M, Torres S, et al
    Monoclonal antibodies directed against cadherin RGD exhibit therapeutic activity against melanoma and colorectal cancer metastasis.
    Clin Cancer Res. 2017 Sep 15. pii: clincanres.1444.2017.
    >> Share

  22. YIN Y, Yao S, Hu Y, Feng Y, et al
    The Immune-microenvironment Confers Chemoresistance of Colorectal Cancer through Macrophage-derived IL-6.
    Clin Cancer Res. 2017 Sep 19. pii: clincanres.1283.2017.
    >> Share

    Dis Colon Rectum

  23. CHANG GJ
    Treatment of Locally Advanced Rectal Cancer: Turning Good Rationale Into Good Evidence?
    Dis Colon Rectum. 2017;60:649-650.
    >> Share

  24. GOMES DA SILVA R, Hanan B, Fonseca LM
    Treatment of Anastomotic Stricture of a Handsewn Coloanal Anastomosis With Transanal Approach.
    Dis Colon Rectum. 2017;60:755.
    >> Share

    Chemotherapy, "Lighting the Fire" or "Releasing the Brakes" in Metastatic Anal Cancer.
    Dis Colon Rectum. 2017;60:757-758.
    >> Share

  26. UEMATSU D, Akiyama G, Sugihara T, Magishi A, et al
    Complete Transanal Total Mesorectal Excision for Lower Rectal Cancer.
    Dis Colon Rectum. 2017;60:872-873.
    >> Share

  27. CHANG GJ
    Can Prognostic Scoring Tools Predict Treatment Outcomes?
    Dis Colon Rectum. 2017;60:875-876.
    >> Share

  28. HERZIG D, Hardiman K, Weiser M, You N, et al
    The American Society of Colon and Rectal Surgeons Clinical Practice Guidelines for the Management of Inherited Polyposis Syndromes.
    Dis Colon Rectum. 2017;60:881-894.
    >> Share

  29. ATALLAH SB, DuBose AC, Burke JP, Nassif G, et al
    Uptake of Transanal Total Mesorectal Excision in North America: Initial Assessment of a Structured Training Program and the Experience of Delegate Surgeons.
    Dis Colon Rectum. 2017;60:1023-1031.
    >> Share

  30. HUPKENS BJP, Martens MH, Stoot JH, Berbee M, et al
    Quality of Life in Rectal Cancer Patients After Chemoradiation: Watch-and-Wait Policy Versus Standard Resection - A Matched-Controlled Study.
    Dis Colon Rectum. 2017;60:1032-1040.
    >> Share

  31. SUN Z, Gilmore B, Adam MA, Kim J, et al
    Adjuvant Chemotherapy After Preoperative Chemoradiation Improves Survival in Patients With Locally Advanced Rectal Cancer.
    Dis Colon Rectum. 2017;60:1050-1056.
    >> Share

  32. KALLENBERG FGJ, Bastiaansen BAJ, Nio CY, Soeters MR, et al
    Adrenal Lesions in Patients With (Attenuated) Familial Adenomatous Polyposis and MUTYH-Associated Polyposis.
    Dis Colon Rectum. 2017;60:1057-1064.
    >> Share

  33. FAZENDIN EA, Crean AJ, Fazendin JM, Kucejko RJ, et al
    Condyloma Acuminatum, Anal Intraepithelial Neoplasia, and Anal Cancer in the Setting of HIV: Do We Really Understand the Risk?
    Dis Colon Rectum. 2017;60:1078-1082.
    >> Share

  34. HUSCHER CGS, Lirici MM
    Transanal Total Mesorectal Excision: Pneumodissection of Retroperitoneal Structures Eases Laparoscopic Rectal Resection.
    Dis Colon Rectum. 2017;60:1109-1112.
    >> Share

    Eur J Surg Oncol

  35. CURRIE AC, Brigic A, Thomas-Gibson S, Suzuki N, et al
    A pilot study to assess near infrared laparoscopy with indocyanine green (ICG) for intraoperative sentinel lymph node mapping in early colon cancer.
    Eur J Surg Oncol. 2017 Aug 23. pii: S0748-7983(17)30643.
    >> Share

  36. POSTON G, Adam R, Xu J, Byrne B, et al
    The role of cetuximab in converting initially unresectable colorectal cancer liver metastases for resection.
    Eur J Surg Oncol. 2017 Aug 10. pii: S0748-7983(17)30605.
    >> Share


  37. JI J, Sundquist J, Sundquist K
    Cholera Vaccine Use Is Associated with a Reduced Risk of Death in Patients with Colorectal Cancer: A Population-based Study.
    Gastroenterology. 2017 Sep 15. pii: S0016-5085(17)36149.
    >> Share

  38. BELLIDO F, Sowada N, Mur P, Lazaro C, et al
    Association Between Germline Mutations in BRF1, a subunit of the RNA Polymerase III Transcription Complex, and Hereditary Colorectal Cancer.
    Gastroenterology. 2017 Sep 11. pii: S0016-5085(17)36142.
    >> Share

  39. BURGESS NG, Hourigan LF, Zanati SA, Brown GJ, et al
    Risk Stratification for Covert Invasive Cancer Among Patients Referred for Colonic Endoscopic Mucosal Resection: A Large Multicenter Cohort.
    Gastroenterology. 2017;153:732-742.
    >> Share

    Gastrointest Endosc

  40. MCGILL SK, Soetikno R, Kaltenbach T
    Optical diagnosis of early colorectal cancer: riding the highs and lows of the Japanese Narrow-Band Imaging Expert Team classification.
    Gastrointest Endosc. 2017;86:710-712.
    >> Share

    Int J Cancer

  41. VEDELD HM, Merok M, Jeanmougin M, Danielsen SA, et al
    CpG island methylator phenotype identifies high risk patients among microsatellite stable BRAF mutated colorectal cancers.
    Int J Cancer. 2017;141:967-976.
    >> Share

  42. DE MARTEL C, Plummer M, Vignat J, Franceschi S, et al
    Worldwide burden of cancer attributable to HPV by site, country and HPV type.
    Int J Cancer. 2017 Apr 1. doi: 10.1002/ijc.30716.
    >> Share

  43. MA B, Gao P, Wang H, Xu Q, et al
    What has preoperative radio(chemo)therapy brought to localized rectal cancer patients in terms of perioperative and long-term outcomes over the past decades? A systematic review and meta-analysis based on 41,121 patients.
    Int J Cancer. 2017;141:1052-1065.
    >> Share

  44. JAYASEKARA H, English DR, Haydon A, Hodge AM, et al
    Associations of alcohol intake, smoking, physical activity and obesity with survival following colorectal cancer diagnosis by stage, anatomic site and tumor molecular subtype.
    Int J Cancer. 2017 Sep 16. doi: 10.1002/ijc.31049.
    >> Share

  45. WANG W, Xiao X, Chen X, Huo Y, et al
    Tumor-suppressive miR-145 co-repressed by TCF4-beta-catenin and PRC2 complexes forms double-negative regulation loops with its negative regulators in colorectal cancer.
    Int J Cancer. 2017 Sep 16. doi: 10.1002/ijc.31056.
    >> Share

  46. POTHOULAKIS C, Torre-Rojas M, Duran-Padilla MA, Gevorkian J, et al
    CRHR2/Ucn2 signaling is a novel regulator of miR-7/YY1/Fas circuitry contributing to reversal of colorectal cancer cell resistance to Fas-mediated apoptosis.
    Int J Cancer. 2017 Sep 20. doi: 10.1002/ijc.31064.
    >> Share

    Int J Colorectal Dis

  47. VERWEIJ NM, Souwer ETD, Schiphorst AHW, Maas HA, et al
    The effect of a geriatric evaluation on treatment decisions for older patients with colorectal cancer.
    Int J Colorectal Dis. 2017 Sep 20. doi: 10.1007/s00384-017-2883.
    >> Share

  48. DOMINGUEZ-COMESANA E, Estevez-Fernandez SM, Lopez-Gomez V, Ballinas-Miranda J, et al
    Procalcitonin and C-reactive protein as early markers of postoperative intra-abdominal infection in patients operated on colorectal cancer.
    Int J Colorectal Dis. 2017 Sep 16. doi: 10.1007/s00384-017-2902.
    >> Share

    J Surg Oncol

  49. SASAKI K, Margonis GA, Andreatos N, Zhang XF, et al
    The prognostic utility of the "Tumor Burden Score" based on preoperative radiographic features of colorectal liver metastases.
    J Surg Oncol. 2017;116:515-523.
    >> Share

    Lancet Oncol

  50. KERR J, Anderson C, Lippman SM
    Physical activity, sedentary behaviour, diet, and cancer: an update and emerging new evidence.
    Lancet Oncol. 2017;18:e457-e471.
    >> Share

  51. GOURD E
    Immune response boosted in metastatic colorectal cancer.
    Lancet Oncol. 2017 Sep 14. pii: S1470-2045(17)30712.
    >> Share


  52. LIU L, Wong CC, Gong B, Yu J, et al
    Functional significance and therapeutic implication of ring-type E3 ligases in colorectal cancer.
    Oncogene. 2017 Sep 18. doi: 10.1038/onc.2017.
    >> Share

    PLoS One

  53. LAMBERTI MJ, Pansa MF, Vera RE, Fernandez-Zapico ME, et al
    Transcriptional activation of HIF-1 by a ROS-ERK axis underlies the resistance to photodynamic therapy.
    PLoS One. 2017;12:e0177801.
    >> Share

  54. PENG YC, Lin CL, Sung FC
    The association between cholecystectomy and colorectal neoplasm in inflammatory bowel diseases: A population-based cohort study.
    PLoS One. 2017;12:e0177745.
    >> Share

  55. IWATA T, Uchino T, Koyama A, Johmura Y, et al
    The G2 checkpoint inhibitor CBP-93872 increases the sensitivity of colorectal and pancreatic cancer cells to chemotherapy.
    PLoS One. 2017;12:e0178221.
    >> Share

  56. LI Z, Li SA, Sun Y, Liu Y, et al
    TNF-alpha -308 A allele is associated with an increased risk of distant metastasis in rectal cancer patients from Southwestern China.
    PLoS One. 2017;12:e0178218.
    >> Share

  57. KURACHA MR, Thomas P, Loggie BW, Govindarajan V, et al
    Bilateral blockade of MEK- and PI3K-mediated pathways downstream of mutant KRAS as a treatment approach for peritoneal mucinous malignancies.
    PLoS One. 2017;12:e0179510.
    >> Share

  58. WANG B, Yang J, Li S, Lv M, et al
    Tumor location as a novel high risk parameter for stage II colorectal cancers.
    PLoS One. 2017;12:e0179910.
    >> Share

  59. OSTENSSON E, Silfverschiold M, Greiff L, Asciutto C, et al
    The economic burden of human papillomavirus-related precancers and cancers in Sweden.
    PLoS One. 2017;12:e0179520.
    >> Share

  60. ZHAN Z, Verberne CJ, van den Heuvel ER, Grossmann I, et al
    Psychological effects of the intensified follow-up of the CEAwatch trial after treatment for colorectal cancer.
    PLoS One. 2017;12:e0184740.
    >> Share

  61. BOOT A, Oosting J, van Eendenburg JDH, Kuppen PJK, et al
    Methylation associated transcriptional repression of ELOVL5 in novel colorectal cancer cell lines.
    PLoS One. 2017;12:e0184900.
    >> Share

  62. DE WIT M, Carvalho B, Delis-van Diemen PM, van Alphen C, et al
    Lumican and versican protein expression are associated with colorectal adenoma-to-carcinoma progression.
    PLoS One. 2017;12:e0174768.
    >> Share

    Semin Oncol

  63. CHEBIB R, Verlingue L, Cozic N, Faron M, et al
    Angiogenesis inhibition in the second-line treatment of metastatic colorectal cancer: A systematic review and pooled analysis.
    Semin Oncol. 2017;44:114-128.
    >> Share

  64. DUCREUX M, Osterlund P, Pignon JP
    Angiogenesis inhibition in the second-line treatment of metastatic colorectal cancer-A definite conclusion?
    Semin Oncol. 2017;44:129-131.
    >> Share

    World J Surg

  65. LIETO E, Auricchio A, Cardella F, Mabilia A, et al
    Fluorescence-Guided Surgery in the Combined Treatment of Peritoneal Carcinomatosis from Colorectal Cancer: Preliminary Results and Considerations.
    World J Surg. 2017 Sep 19. doi: 10.1007/s00268-017-4237.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016